US67080N1019
US67080N1019
Nuvation Bio Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 62.902.000 | 7.873.000 | 699.0% |
| Cost of Revenue | 9.298.000 | 7.078.000 | 31.4% |
| Gross Profit | 53.604.000 | 795.000 | 6642.6% |
| 266.668.000 | 168.352.000 | 58.4% | |
| Operating Income | -213.064.000 | -167.557.000 | 27.2% |
| Pretax Income | -204.627.000 | -567.939.000 | 64.0% |
| Net Income Common Stockholders | -204.627.000 | -567.939.000 | 64.0% |
| -- | -- | -- | |
| -- | -- | -- |